CSPG5 and schizophrenia: It has been reported that ErbB3 is associated with schizophrenia in a Caucasian population (Li et al., 2009), and thus there is a possibility that neuroglycan C-ErbB3 signaling is involved in the pathophysiology of schizophrenia.